Cargando…
The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals
BACKGROUND: Direct-acting antiviral (DAA) drugs have been effective in the treatment of chronic hepatitis C virus (HCV) infection. Limited data are available on safety, tolerability, and efficacy in American Indian or Alaska Native people. We aim to evaluate the treatment outcomes of sofosbuvir- bas...
Autores principales: | Townshend-Bulson, Lisa, Roik, Elena, Barbour, Youssef, Bruden, Dana J. T., Homan, Chriss E., Espera, Hannah G. F., Stevenson, Timothy J., Hewitt, Annette M., Rhodes, Wileina, Gove, James E., Plotnik, Julia N., Snowball, Mary M., McGilvray, John, Simons, Brenna C., Johnston, Janet M., McMahon, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639063/ https://www.ncbi.nlm.nih.gov/pubmed/34855920 http://dx.doi.org/10.1371/journal.pone.0260970 |
Ejemplares similares
-
Autoimmune hepatitis and overlap syndrome among Alaska Native people: Prevalence, clinical characteristics, and remission
por: Johnston, Janet M., et al.
Publicado: (2023) -
Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C
por: Livingston, Stephen E., et al.
Publicado: (2016) -
Observed Changes in Natural Killer and T cell Phenotypes with Evaluation of Immune Outcome in a Longitudinal Cohort Following Sofosbuvir-Based Therapy for Chronic Hepatitis C Infection
por: Stevenson, Timothy J, et al.
Publicado: (2019) -
Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection
por: Livingston, Stephen E., et al.
Publicado: (2012) -
Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016
por: Bressler, Sara S., et al.
Publicado: (2022)